Nov 15 (Reuters) – The US FDA on Sunday declined to approve Summit Therapeutics' lung cancer drug, dealing a setback to the efforts to bring a new treatment for patients who have limited options after
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Shelton battles past Fils in ATP Finals opener
VIDEO SHOWS: ATP FINALS JOHN MCENROE GROUP HIGHLIGHTS WITH BEN SHELTON BEATING ARTHUR FILS SHOWS:…
Colts edge lowly Dolphins to snap 5-game slide
Jonathan Taylor and Seth McGowan combined for 160 yards and a touchdown rushing to help…
Coles probes cyber security incident, says no evidence customer data compromised
Nov 16 (Reuters) - Australian retailer Coles Group said on Monday it is currently investigating…
